CHF Solutions Inc (NQ: CHFS )
5.280 USD UNCHANGED Last Price Updated: 6:04 PM EDT, Apr 26, 2021 Add to My Watchlist
Press releases about CHF Solutions Inc
CHF Solutions, Inc. Announces Third Quarter Financial Results and Provides Company Update
November 05, 2019
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
November 04, 2019
CHF Solutions, Inc. Announces Sales Force Realignment To Increase Focus On Cardiac Surgery And Eventually Pediatrics
November 01, 2019
CHF Solutions, Inc. To Announce Third Quarter 2019 Financial Results and Corporate Update on November 5, 2019
October 29, 2019
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering
October 23, 2019
CHF Solutions to Exhibit at The American College of Chest Physicians (CHEST) Annual Meeting 2019
October 17, 2019
CHF Solutions Announces that James A. Haley Veterans’ Hospital Receives Final Approval To Initiate Heart Failure Outpatient Study utilizing Aquadex FlexFlow® System
October 10, 2019
First Study of Aquadex FlexFlow System Sponsored by United States Veterans Administration for Aquapheresis Treatment in Patients Suffering from Fluid Overload. First patient enrollment expected in the...
CHF Solutions, Inc. to Present at the MicroCap Rodeo Investor Conference on October 15, 2019
October 08, 2019
CHF Solutions To Exhibit at Upcoming Heart Failure Conferences
October 03, 2019
CHF Solutions submits 510(k) application for Use of Aquadex FlexFlow® System with Pediatric Patients
October 01, 2019
Multi-Center, Retrospective Study Evaluates Use of Ultrafiltration Therapy with Aquadex FlexFlow® System in Pediatric Patients
September 24, 2019
CHF Solutions, Inc. to Present at the Ladenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019
September 19, 2019
CHF Solutions, Inc. to Host a Call with Investigator Panel to Discuss Results of a Study Involving Use of Aquadex FlexFlow® in Pediatric Patients on September 25, 2019
September 17, 2019
CHF Solutions, Inc. to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
September 10, 2019
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 06, 2019
CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company’s Board of Directors
September 04, 2019
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, announced today that its Board of Directors has elected each of John L. Erb and Gregory J. Fluet to serve...
New Publication Highlights Transient Increases in Creatinine or Tubular Injury Markers in Heart Failure Patients Should Not Dissuade Use of Ultrafiltration
August 08, 2019
CHF Solutions, Inc. Announces 53 Percent Increase in Revenues for Second Quarter 2019 Over Previous Year and 38 Percent Increase from Q1 2019
August 06, 2019
CHF Solutions, Inc. To Announce Second Quarter 2019 Financial Results and Corporate Update on August 6, 2019
July 30, 2019
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2019 financial results will be released on Tuesday, August 6, 2019. The company will host a conference call and webcast at...
Texas Health Resources Launches Ultrafiltration Therapy Using CHF Solutions’ Aquadex FlexFlow® System
July 16, 2019
CHF Solutions (Nasdaq: CHFS) today announced that the Texas Health Resources hospital system has initiated the offering of ultrafiltration therapy using the company’s Aquadex FlexFlow system.
CHF Solutions To Exhibit At the American Association of Heart Failure Nurses 15th Annual Meeting
June 25, 2019
CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 15th Annual Meeting of the American Association of Heart Failure Nurses (AAHFN) June 27-29, 2019 at the JW Marriott Austin in...
CHF Solutions Sponsored AATS Session on Post-Cardiac Surgery, Highlighting Benefits of Using the Aquadex FlexFlow® System Following Cardiac Surgery
June 13, 2019
The Session, Titled “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies” Moderated by Daniel Beckles, M.D., Ph.D., Highlighted Benefits Such as More Rapid...
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on May 23, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material...
CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare
May 15, 2019
CHF Solutions (Nasdaq: CHFS) today announces that Sussex County, Delaware-based health system, Beebe Healthcare, has initiated offering ultrafiltration therapy using the company’s Aquadex FlexFlow...
CHF Solutions, Inc. Announces 17 Percent Increase in Revenues for First Quarter 2019 Over Previous Year and Provides Company Update
May 07, 2019
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the first quarter ended March 31, 2019, which included the following highlights:
CHF Solutions (Nasdaq: CHFS) today announces it has hired Nestor Jaramillo, Jr. as its new chief commercial officer, effective May 7, 2019.
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019. The company will host a conference call and webcast at 9:00 AM...
CHF Solutions to Sponsor CT Theatre Session, “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies” Moderated by Renowned Cardiothoracic Surgeon Daniel Beckles, M.
April 23, 2019
CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a CT Theatre Session at the American Association for Thoracic Surgery Annual Meeting on Monday, May 6, 2019, 1:00-1:30 pm at the...